Evaluation of Endometriosis With 18F-fluoroestradiol PET / MRI

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 7, 2020

Primary Completion Date

July 11, 2022

Study Completion Date

July 11, 2022

Conditions
Endometriosis
Interventions
DRUG

18F-fluoroestradiol

Patients will receive the FES tracer during a PET/MRI scan

Trial Locations (1)

27599

UNC Hospitals, Chapel Hill

All Listed Sponsors
collaborator

North Carolina Translational and Clinical Sciences Institute

OTHER

lead

University of North Carolina, Chapel Hill

OTHER